Current diagnostic and therapeutic strategies for COVID-19
Authors:
Open Access
- 1 April 2021
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 11 (2) , 129-137
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 94 references indexed in Scilit:
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal modelCell Research, 2012
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosidesBioorganic & Medicinal Chemistry Letters, 2012
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st centuryInternational Journal of Antimicrobial Agents, 2007
- Lopinavir/RitonavirDrugs, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Broadly Reactive and Highly Sensitive Assay for Norwalk-Like Viruses Based on Real-Time Quantitative Reverse Transcription-PCRJournal of Clinical Microbiology, 2003